New diagnostic test stratifies the likelihood of immunotherapy benefit across solid tumors
28 April, 2023
3DSecret funded by European Innovation Council’s Pathfinder Open 2022, established under the EU Horizon Europe program. Consortium to leverage novel microfluidic technology to culture 3D cancer models for multi-parametric analysis, to inform cancer diagnostic and therapeutic development
27 April, 2023
(MIAMI) Researchers at the John P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine have found that variations in chromatin accessibility, and thus gene expression, may explain why people of European descent with APOE4 gene variants have a greater risk of developing Alzheimer’s disease than people of African descent with similar genetics.
24 April, 2023
Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.
21 April, 2023
Global integrated drug discovery company, Sygnature Discovery and global healthcare group Daewoong Pharmaceutical, have entered into a research collaboration agreement to accelerate the discovery of a novel small molecule to target autoimmune disease.
20 April, 2023
The home of the UK’s lab industry expands floor plan to accommodate increased interest in this year’s show
18 April, 2023
A retrospective chart review interim analysis demonstrated that cefiderocol achieved clinical cure in 65% and 60% of patients with Pseudomonas aeruginosa and Acinetobacter baumannii respectively, the majority of whom were severely ill with comorbidities.
17 April, 2023
Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023
14 April, 2023